Needle-free injection system is an innovative way to introduce medication into a patient’s body. Unlike the conventional needle injection system, needle-free injection do not penetrate through the skin. Needle-free injection system is steadily emerging as an efficient way to administer the medication with better patient compliance. There are various advantages offered by needle-free injection system. This system offers efficiency in administration of medication with better patient compliance especially for children (vaccination), geriatric patients (palliative and other care), and patients with chronic diseases such as diabetes, GI tract disease, and multiple sclerosis who need daily injection administration. Self-medication becomes convenient with needle-free injection due to increased confidence amongst user for self-medication and therefore it offers better treatment adherence and improved quality of life. Needle-free injection eliminates needle phobia, as medication is administered through system such as jet injection system to the skin. Moreover, needle-free injection system allows drug delivery of even viscous drug, which is difficult with conventional needle syringe system. Needle-free injection system also allows efficient delivery of biological drugs, which are unstable due to risk of protein denaturation. This is possible as needle-free injection system maintains biological integrity and it does not have silicon oil or tungsten material in its primary container. It is reusable and delivers drug faster, as compared to conventional needle syringe system due to hair size jet stream through which drug is administered.

Market Dynamics

Needle-free injection system is continuously expanding its market footprint on account of various factors. Increasing incidence of needle associated injuries and needle phobia amongst children and adults is expected to drive growth of needle-free injection system market. According to a study published in Behavioral Neurology, 2014, around 3-4 % of the world population faces needle phobia. This impacts their hospital or clinic visits, as they avoid visiting such facilities due to fear of exposure to needles. Needle phobia also impacts the vaccination amongst children, as most of them perceives injecting vaccine as a painful procedure. According to a study published in the Clinical Journal of Pain in 2015, there were 12 billion vaccination every year worldwide, most of which required injecting drug with a needle syringe system. Increasing demand for vaccines and other biologic products is another factor boosting growth of the needle-free injection system market. According to the World Health Organization (WHO) 2018, globally around 86% of infants are vaccinated against 26 diseases, however, 19.5 million children are unvaccinated leading to death of 2-3 million children every year. Chronic disease such as diabetes often needs daily dose of insulin, which has to be administered through pain needles. This may lead to lack of adherence to treatment due to lack of confidence to self-inject insulin. Increasing research on biologics and biosimilar is another factor expected to fuel growth of the market. Biologicals are increasingly launched and prescribed to treat disease such as GI tract disease (ulcerative colitis and Crohn’s disease), central nervous system associated disease (multiple sclerosis and Alzheimer’s disease), and cancer. Other factors such as increasing incidence of communicable diseases caused due to conventional needle, increasing geriatric population worldwide who need palliative care, and growing awareness about safe injection practices are also expected to drive growth of needle-free injection system market.

However, per unit cost of needle-free injection may restrain the market growth. As this system is relatively new and do not have wider penetration yet, its use is still very limited. Moreover, developing economies where vaccine need is increasing with growing population would find it difficult to access this product.

Regional Insights

On the basis of geography, the global needle-free injection system market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is a dominant region in the global needle-free injection system market. This is due to high prevalence of chronic diseases such as diabetes and cancer. According to the American Cancer Society, 2018, cancer is the second leading cause of death after cardio vascular disease in the U.S. Furthermore, around 1.7 million new cancer cases were reported by 2017 in this region. Rising number of biologic drug approval in the U.S. is another factor driving growth of needle-free injection system market. For instance, according to the data published by the U.S. FDA (United States Food and Drug Administration) in the year 2017, more than 20 biologic formulation received FDA approval. Asia Pacific is witnessing high growth in the needle-free injection system market, as vaccine need is highest in this region. Moreover, this region has high prevalence of lifestyle disease such as diabetes. According to the 2017 Diabetes Atlas report, there were over 240 million diabetes patients in this region.

Competitive Landscape

Some of the key players operating in the market include Antares Pharma, Inc., Endo International plc, Portal Instruments, Inc., Zogenix, PharmaJet, Bioject Medical Technologies Inc., Medical International Technology, Inc., PenJet Corporation, INJEX Pharma AG, National Medical Products Inc., Valeritas, Inc., European Pharma Group, and Crossject SA.

Collaborations amongst companies to develop the needle-free injection system would also boost growth of needle-free injection system market. For instance, in November 2017, Takeda Pharmaceutical and Portal Instruments entered into collaboration agreement to develop the needle-free drug delivery device with the Takeda Pharmaceuticals biologic medicines for hepatitis, Crohn's disease etc.

Market Taxonomy

On the basis of product type:

  • Prefilled
  • Fillable

On the basis of delivery site:

  • Subcutaneous Injectors
  • Intramuscular Injectors
  • Intradermal Injectors

On the basis of product lifecycle:

  • Disposable
  • Reusable

On the basis of technology:

  • Jet-based needle free injector
  • Spring-based needle free injector
  • Laser-powered needle free injector

On the basis of application:

  • Vaccine and other biologic product delivery
  • Insulin Delivery
  • Others

On the basis of end user:

  • Hospitals & Clinics
  • Home based care

On the basis of geography:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users